The new relationship between New York-listed Star Bulk and 10% investor John Fredriksen looks nothing but friendly for now, but the Greek company has a remedy available just in case.
Informally known as a “poison pill”, there are anti-takeover provisions built into Star Bulk’s bylaws that could prevent the Norwegian tycoon or anyone else from aggressively accumulating a controlling position.
